Velocity’s Hallandale Beach research site was founded in 2005 as MD Clinical by two board-certified neurologists, Dr. Beth Safirstein and Dr. Kerri Wilks, and acquired by Velocity in 2018. The center focuses on clinical trials for neurology and psychiatry indications, including Alzheimer’s Disease and other memory impairment conditions, major and bipolar depression, Parkinson’s Disease, and migraine. A wide range of Sleep Disorder studies, including primary insomnia and Circadian Rhythm Disorders are conducted in our fully equipped Sleep Laboratory. In addition, the Hallandale Beach site has a dedicated and secured Phase I Unit.
Our bi-lingual research team recruits and enrolls large numbers of Latinx study participants. By developing positive relationships and understanding family interactions in this demographic, Hallandale Beach more easily recruits elderly and other sub-populations of participants. Accessible to several major highways, this ADA compliant facility serves Miami and other South Florida areas. With more than 9500 square-feet of dedicated research space, they can efficiently and effectively conduct multiple concurrent studies.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Hallandale Beach team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.
